Philadelphia Study Examines GLP-1 Medication Knowledge

A survey of 52 adults explores public understanding and household impacts of GLP-1 drugs.

Updated on Oct. 27, 2026 in Weight Loss

Gouache-painted illustration of a ceramic mortar and pestle on a plain table, representing public health knowledge and medical wellness. — A recent Temple University study of Philadelphia adults reveals high public familiarity with GLP-1 medications, though misconceptions regarding approved usage remain common. AI Illustration. Upload story photo >

Live Poll

Do you trust clinical advice more than commercial advertisements when researching new medical treatments?

Between November 2024 and April 2025, researchers at Temple University surveyed 52 adult patients in Philadelphia regarding their awareness of GLP-1 medications. The study highlights significant public familiarity with these drugs alongside common misconceptions about their approved uses.

Why it matters

Understanding how patients gather health information helps researchers identify gaps in clinical guidance and the potential influence of direct-to-consumer advertising. The findings shed light on how medication knowledge affects household dietary behaviors.

A survey of 52 adults found that 98% of participants were aware of GLP-1 medications, while 73% cited commercial advertisements as their primary source of information. Notably, 87% of respondents expressed a preference for receiving medical guidance directly from a clinician.

The players

Temple University

This public research university in Philadelphia led the study on patient medication awareness.

The details

The study involved recruiting participants from four Philadelphia outpatient clinics, resulting in a mean participant age of 38.9 years. Respondents showed varying levels of drug indication awareness, with 88% associating the drugs with obesity treatment, 75% with diabetes, and 43% with high blood pressure management.

The survey was conducted from November 2024 to April 2025.

Health Landscape

This research provides a local perspective on the rapidly evolving public understanding of weight loss treatments. It adds to the ongoing clinical investigation into GLP-1 receptor agonist treatment protocols by highlighting the specific influence of consumer-facing advertising.

The findings suggest that patients often rely on advertisements for medical information rather than clinical consultations. Residents are encouraged to discuss weight management medications directly with their healthcare providers to ensure they receive accurate, tailored medical advice.

The takeaway

Patients should prioritize professional medical advice over insights gathered from commercial media. Verifying health information with a clinician remains the safest approach for those considering new weight management treatments.